Previously, we found that TGase 2 inhibition induces cell death by p53 stabilization.2 Therefore, RCC may evade doxorubicin-induced cell death if the stabilized p53 is depleted by a TGase 2-mediated autophagy process through transportation to p62. The gene discussed is TP53; the disease is renal cell carcinoma.